Delivery Order SPE2DB22D1202-SPE2DB24FVFN2

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award for $1,079.94 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of 1,000 units of 20 mg Simvastatin tablets. The contract has an ultimate completion date of February 2, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.16 firm fixed-price delivery order contract is for the supply of 4,566,948,919 units of Simvastatin 20 mg tablets. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,284.84 contract is for the delivery of 1,000 units of the drug Simvastatin 40 mg tablets by May 20, 2025. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 1,000 tablets of the prescription medication Simvastatin 10 mg, a common cholesterol-lowering drug. The contract has a firm fixed price of $1,458.17 and a performance period through June 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Simvastatin 40 mg tablets in quantities of 1,000 tablets. The contract is a firm-fixed-price, delivery order contract with a ceiling value of $3,332.84 and a performance period through August 8, 2023. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a $1,103.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 1,000 units of the prescription medication Simvastatin 40 mg tablets. The contract has an ultimate completion date of June 23, 2025 and was awarded on June 20, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SIMVASTATIN 20 MG TABLET 1000S. The contract is a Firm Fixed Price, Delivery Order type, with a ceiling value of $1,958.08 and a completion date of December 19, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Pitavastatin 2 mg tablets. The $1,996.37 firm fixed-price delivery order contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of Simvastatin 40 mg tablets, a medication used to treat high cholesterol. The contract has a ceiling value of $2,731.50 and is a firm fixed-price delivery order. The period of performance extends to July 3, 2025. This contract is not designated as a set-aside...
This federal contract award is for $2,698.87 and was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for ezetimibe 10 mg tablets, a cardiovascular medication, with a completion date of July 2, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVFN2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,763.52, is a Delivery Order for the supply of 4,565,047,099 tablets of Simvastatin 40 mg. The award has an ultimate completion date of July 2, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific contract award is not designated with a set-aside requirement, indicating open competition.

Generated 5/17/25, 10:06 AM